Common drugs may cut COVID hospitalizations, study hopes
NCT ID NCT05504057
First seen Mar 25, 2026 · Last updated May 23, 2026 · Updated 9 times
Summary
This study is checking if people who already take antihistamines (like allergy meds) or amantadine (a Parkinson's drug) have milder COVID-19 and fewer hospital stays. Researchers will track over 140,000 patients to see if these drugs lower the chance of serious illness or death from COVID-19. The goal is to find cheap, available treatments that could help control the disease.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Hospital de Terrassa
RECRUITINGTerrassa, Barcelona, 08227, Spain
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hospital of Terrassa
RECRUITINGTerrassa, Barcelona, 08227, Spain
Contact
Conditions
Explore the condition pages connected to this study.